Yes www.drugs.com: Monitor: monoamine oxidase inhibitors (maois) can potentiate the cardiovascular adverse effects of beta-adrenergic agonists such as hypertension, palpitation, tachycardia, and chest pain. Management: cardiovascular status should be closely monitored during coadministration of beta-adrenergic agonists with maois or other agents that possess maoi activity. Best wishes.
Answered 11/20/2013
4.7k views
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
2 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question